NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.17 +0.17 (+0.22%) GOLD FUTURES
2,317.00 +6.00 (+0.26%) DOW
38,263.92 +360.63 (+0.95%) Bitcoin GBP
47,413.05 +298.45 (+0.63%)
Baxter International Inc. (BAX)
| Previous close | 40.34 |
| Open | 39.10 |
| Bid | 36.73 x 1000 |
| Ask | 36.75 x 1100 |
| Day's range | 36.20 - 39.15 |
| 52-week range | 31.01 - 50.21 |
| Volume | |
| Avg. volume | 3,643,913 |
| Market cap | 18.875B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.16 (2.88%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | N/A |
- Business Wire
Baxter Reports First-Quarter 2024 Results
DEERFIELD, Ill., May 02, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
- Business Wire
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
DEERFIELD, Ill., April 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
- Business Wire
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
DEERFIELD, Ill., April 10, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I215737 to pre-register for the call and receive the call information.
